Standard and Poor's 500 Guide, 2007 EditionMcGraw-Hill, 2006 - 1032 páginas This work reports on the 500 companies making up the new Standard & Poor 500 and gauges the growth and stability of each stock's earnings. Entries for each company are packed with information such as data on earnings and dividends. |
Contenido
Epogen is a genetically engineered version of human erythropoietin EPO | 2 |
ADIs products are sold both to OEMs and to customers building their | 4 |
MARKET PROFILE At December 31 2005 ASO operated more than 675 bank | 13 |
Derechos de autor | |
Otras 52 secciones no mostradas
Términos y frases comunes
12-month target price 30-Week Mov 52-Wk Range based on S&P Cash Flow CBOE Chrmn Common Shares Outstg company reports Core EPS 2007E Current Assets Current Liabilities Data as orig disc opers/spec Disclosures and Analyst Dividend Rate/Share Yield Earnings Per Share earnings report expected Effective Tax Rate Ended Dec EPS diluted EPS Estimates based Financial Data Million GICS Sector growth historical GAAP earnings Invested 5 Yrs Investment Rationale/Risk Key Stock Statistics Long Term Debt McGraw-Hill Companies Nil Nil Nil NM NM NM NM-Not Meaningful NR-Not Ranked orig reptd P/E on S&P Relative Strength Rank Return on Assets Return on Equity Return on Revenue Revenue/Earnings Data S&P Core Earnings S&P Core EPS S&P Credit Rating S&P Operating Earnings S&P Quality Ranking Share Data Statement Analysis Million Statistics Source S&P stock option expense Stock Statistics Source Trailing 12-Month EPS Trailing 12-Month P/E UR-Under Review Volume Above Avg ΝΑ ΝΑ ΝΑ